No Data
The Hong Kong Securities and Futures Commission has initiated legal proceedings against Kingnine Healthcare Limited (00648), former directors, and de facto directors.
The Hong Kong Securities and Futures Commission is proceeding with legal proceedings in the original court pursuant to Section 214 of the Securities and Futures Ordinance, seeking a court order to disqualify seven former directors and two former de facto directors of Beijing Jiu Kang Medical Company (00648) for alleged breaches of fiduciary duty.
Healthcare company JKY Medical (00648) released its interim performance, with shareholders' attributable loss of 6.093 million Hong Kong dollars, a 57.28% year-on-year increase in widening.
Jiuku Kangliao (00648) announced its interim results for the six months ending on June 30, 2024, during which the group achieved revenue...
SOFTMEDX-NEW: 2024 INTERIM REPORT
SOFTMEDX-NEW: 2024 INTERIM RESULTS
China Jiuhua Health Industry Corporation Limited (00648.HK) plans to hold a board of directors meeting on August 30 to approve its interim performance.
Kang Lai Health (00648.HK) announced on August 19th that the board of directors will hold a board meeting on Friday, August 30th, 2024 to approve the publication of unaudited interim results for the company and its subsidiaries as of June 30th, 2024.
Lin Pinzhuo has been promoted from an independent non-executive director to an executive director of Kingmed Diagnostics (00648.HK).
On August 1, Gleamray announced that starting from August 1, 2024: (i) Lin Pinzhuo has been transferred from the company's independent non-executive director to executive director; (b) he has been transferred from the chairman of the nomination committee to a member of the nomination committee; (c) appointed as the authorized representative of the company and resigned as a member of the audit committee; (ii) Le Kewei has been appointed as an independent non-executive director of the company, chairman of the nomination committee, and member of the audit committee, remuneration committee, and risk management committee; (iii) Tang Cuihuan Has been appointed as the independent non-executive director and audit committee member of the company; (iv)
No Data
No Data